The Global Fund wants to raise $15 billion for 2014–2016. The Fund announced the target in a news release issued on the eve of the pre-replenishment meeting in Brussels, Belgium on 9–10 April.
You are here
Changes to the charter of the Office of the Inspector General (OIG) adopted by the Global Fund Board specify that when the OIG conducts country audits, it will not evaluate programme impact.
From now on, annual disbursement decisions and semi-annual reporting will be adopted for all Global Fund grants. The only exception will be for grants whose risk profile requires shorter disbursement decisions or more frequent reporting.
These are part of the changes introduced in February 2013 as part of the Global Fund’s Better Grants for Improved Impact Project.
The Global Fund Board has appointed Dr Nafsiah Mboi, Minister of Health in Indonesia, as the next Chair of the Board. It has also appointed Mireille Guigaz as the next Vice-Chair. Ms Guigaz currently represents France on the Board. Dr Mboi does not currently sit on the Board. Both appointments are effective at the end of the 29th Board meeting in June 2013; the two terms will run until the end of the first Board meeting in 2015.
The Eurasian Harm Reduction Network has released a policy brief on “The Global Fund’s New Funding Model: What It Might Mean for You and Your Country.” The brief is based on research in four countries in Eastern Europe and Central Asia (EECA): Armenia, Georgia, Moldova and Uzbekistan.
Global Fund Executive Director Mark Dybul says that the disease split for the funding allocated to early and interim applicants in the transition phase of the new funding model (NFM) should not be viewed in isolation, but rather in the context of all funding for 2013–2014.
The Developed Country NGO delegation on the Global Fund Board has issued a call for nominations for the position of Board member. The position has a two-year term: July 2013–June 2015. The deadline for applications is 8 April 2013.
The Global Fund Board has selected Dr Mark Dybul to serve as the Fund’s next Executive Director. He previously served as head of the US President’s Emergency Program for AIDS Relief (PEPFAR). The decision was made by the Board on 15 November at its 28th meeting in Geneva, and the appointment will take effect in early February.
On 12 October 2012, the Global Fund Secretariat submitted a paper containing options and recommendations for the design of the new funding model to the Strategy, Investment and Impact Committee (SIIC) of the Global Fund Board. The SIIC will discuss the paper at its meeting in Geneva of 24–26 October 2012.
The future of the Affordable Medicines Facility–malaria (AMFm) will be decided at the Global Fund Board meeting on 14–15 November 2012. The outcome appears anything but certain. The AMFm was launched as a two-year pilot phase in April 2009 and began operations in July 2010. The AMFm is hosted by the Global Fund but its programme funding comes from other donors.